India to Tunisia: Pyrazinamide Export Trade Route

The India to Tunisia Pyrazinamide corridor is one of India's established pharmaceutical export routes, with 5 shipments documented worth a combined $78.5M USD. The route is dominated by MACLEODS PHARMACEUTICALS LTD, which alone accounts for roughly 100% of all export value, reflecting the consolidated nature of India's pyrazinamide manufacturing sector.

Across 2 active suppliers, the average shipment value stands at $15.7M USD — a figure that reflects both bulk commercial orders from large pharmaceutical companies and smaller specialty shipments. Sea freight dominates at 74% of all shipments, consistent with pyrazinamide's non-urgent bulk-order profile.

Shipment activity peaks during January–March, with an average transit time of 33 days port-to-port. The route has recorded an annual growth rate of 10.2%, placing it at rank #13 among India's top pyrazinamide export destinations globally.

On the import side, key buyers of Indian pyrazinamide in Tunisia include LA PHARMACIE CENTRALE DE TUNISIE, TO THE ORDER OF, PHARMACIE CENTRALE DE TUNSIE. LA PHARMACIE CENTRALE DE TUNISIE is the single largest importer with 3 shipments valued at $78.4M USD.

India's pyrazinamide exports to Tunisia are driven primarily by a handful of large-scale manufacturers. MACLEODS PHARMACEUTICALS LTD with 4 shipments leads the pack, a pattern common in generic pharmaceutical corridors where manufacturing scale creates significant cost advantages. The presence of 2 active exporters signals a competitive but concentrated market — buyers in Tunisia benefit from supplier diversity while the top tier handles the majority of volume.

The top 3 suppliers — MACLEODS PHARMACEUTICALS LTD, SWISS PARENTERALS LIMITED — together account for 100% of total trade value on this route. The average shipment value of $15.7M USD reflects primarily bulk commercial orders from large pharmaceutical distributors.

Beyond the primary product category, shipments on this route include closely related formulations such as pharmaceutical goods/harmless medicinesfor human use-pyrazinamide tablets bp 500mg (3000 packs) and drugs and pharmaceuticals harmlessmedicines rifampicin, isoniazid and pyrazinamide dispersible tablets (75 m, suggesting that buyers in Tunisia tend to consolidate orders across related product lines from the same Indian supplier.

On the buying side, LA PHARMACIE CENTRALE DE TUNISIE is the largest importer with 3 shipments worth $78.4M USD — representing 100% of all pyrazinamide imports from India on this route.